Publicacións en colaboración con investigadores/as de Universitat Internacional de Catalunya (14)

2024

  1. Novel risk loci for COVID-19 hospitalization among admixed American populations

    eLife, Vol. 13

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Effects and safety of hypertonic saline combined with airway clearance in non-hospitalized children with recurrent wheezing

    Hong Kong Physiotherapy Journal, Vol. 43, Núm. 2, pp. 105-115

2022

  1. Differences in the diabetogenic effect of statins in patients with prediabetes. The PRELIPID study

    Medicina Clinica, Vol. 158, Núm. 11, pp. 531-539

  2. Justification for 24/7 clinical microbiology services

    Enfermedades Infecciosas y Microbiologia Clinica

  3. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

2021

  1. Incidence, diagnosis, and outcome of immune-mediated thrombotic thrombocytopenic purpura: A nationwide survey by the Spanish registry of thrombotic thrombocytopenic purpura

    Journal of Clinical Apheresis, Vol. 36, Núm. 4, pp. 563-573

  2. Looking for a cutoff value for the decongestant test in children suffering with turbinate hypertrophy

    European Archives of Oto-Rhino-Laryngology, Vol. 278, Núm. 10, pp. 3821-3826

2020

  1. Gender differences in health-related quality of life in patients with systolic heart failure: Results of the vida multicenter study

    Journal of Clinical Medicine, Vol. 9, Núm. 9, pp. 1-15

  2. Impact of changes in the WHO's 2019 update of DDDs on the measurement of adult hospital antibacterial consumption in Catalonia (Spain), 2008-18

    JAC-Antimicrobial Resistance, Vol. 2, Núm. 4

  3. Online education about end-of-life care and the donation process after brain death and circulatory death. Can we influence perception and attitudes in critical care doctors? A prospective study

    Transplant International, Vol. 33, Núm. 11, pp. 1529-1540

2017

  1. Geographical variation in therapy for bloodstream infections due to multidrug-resistant Enterobacteriaceae: a post-hoc analysis of the INCREMENT study

    International Journal of Antimicrobial Agents, Vol. 50, Núm. 5, pp. 664-672

2014

  1. La amenaza de las enterobacterias productoras de carbapenemasas en España: Documento de posicionamiento de los grupos de estudio GEIH y GEMARA de la SEIMC

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 32, Núm. 10, pp. 666-670

2013

  1. A review of the factors influencing antimicrobial prescribing

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 31, Núm. SUPPL. 4, pp. 12-15